Related Experiment Videos
Surgical aspects of systemic necrotizing vasculitis
Surgery
|January 1, 1985
Summary
Systemic necrotizing vasculitis (SNV) often affects the gastrointestinal and pulmonary systems. Treatment with cyclophosphamide and prednisone achieved high remission rates, but many patients required surgery for diagnosis or complications.
Area of Science:
- Medicine
- Rheumatology
- Immunology
Background:
- Systemic necrotizing vasculitis (SNV) is a group of rare disorders.
- Polyarteritis nodosa is a common type of SNV.
- SNV can affect multiple organ systems, including the gastrointestinal and pulmonary systems.
Purpose of the Study:
- To review the clinical manifestations, treatment, and outcomes of patients with SNV of the polyarteritis nodosa type.
- To evaluate the efficacy of cyclophosphamide and prednisone in treating SNV.
- To identify risk factors for complications in SNV patients.
Main Methods:
- Retrospective review of 30 patients with SNV.
- Analysis of clinical data, including organ involvement, surgical procedures, and arteriographic findings.
- Evaluation of treatment response to cyclophosphamide and prednisone.
Main Results:
- Gastrointestinal and/or pulmonary involvement was observed in 72% of patients.
- Remission was achieved in 96% of patients treated with cyclophosphamide and prednisone.
- 60% of patients underwent major surgery for diagnosis or complications; pulmonary complications occurred only in patients with pulmonary infiltrates.
Conclusions:
- SNV of the polyarteritis nodosa type frequently involves the GI and pulmonary systems.
- Cyclophosphamide and prednisone are effective treatments for SNV, achieving high remission rates.
- Surgery is often necessary for diagnosis and management of complications, and pulmonary infiltrates are associated with pulmonary complications.